https://mibiz.com/sections/health-care/with-77m-in
Post# of 72440
The investment reflects the continued maturity of venture capital-backed companies in Michigan, many of which started years ago and have steadily progressed in developing medical innovations, said attorney Phil Torrence, managing partner at the Kalamazoo office of Honigman LLP, who represented Ablative Solutions in the deal.
The investment’s size and the involvement of a global venture capital fund could bring added attention to the life sciences sector in Michigan, Torrence said.
“It’s a great win for everybody involved. We still have a way to go, but it definitely puts us on the map,” he said.